These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33233983)

  • 1. Autoimmune encephalitis: novel therapeutic targets at the preclinical level.
    Sell J; Haselmann H; Hallermann S; Hust M; Geis C
    Expert Opin Ther Targets; 2021 Jan; 25(1):37-47. PubMed ID: 33233983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study.
    Heine J; Ly LT; Lieker I; Slowinski T; Finke C; Prüss H; Harms L
    J Neurol; 2016 Dec; 263(12):2395-2402. PubMed ID: 27604620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of plasma exchange in patients with autoimmune encephalitis.
    Zhang Y; Huang HJ; Chen WB; Liu G; Liu F; Su YY
    Ann Clin Transl Neurol; 2021 Apr; 8(4):763-773. PubMed ID: 33609012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunobiology of autoimmune encephalitides.
    Alexopoulos H; Dalakas MC
    J Autoimmun; 2019 Nov; 104():102339. PubMed ID: 31611142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis.
    Wickel J; Chung HY; Platzer S; Lehmann T; Prüss H; Leypoldt F; Günther A; Scherag A; Geis C;
    Trials; 2020 Jul; 21(1):625. PubMed ID: 32641101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-Mediated Autoimmune Encephalitis in Childhood.
    Brenton JN; Goodkin HP
    Pediatr Neurol; 2016 Jul; 60():13-23. PubMed ID: 27343023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimmunological antibody-mediated encephalitis and implications for diagnosis and therapy in neuropsychiatry.
    Marinas JE; Matveychuk D; Dursun SM; Baker GB
    Acta Neuropsychiatr; 2020 Aug; 32(4):177-185. PubMed ID: 31791436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune Encephalitis: Current Knowledge on Subtypes, Disease Mechanisms and Treatment.
    Nissen MS; Ryding M; Meyer M; Blaabjerg M
    CNS Neurol Disord Drug Targets; 2020; 19(8):584-598. PubMed ID: 32640967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune Movement Disorders.
    Fearon C; O'Toole O
    Semin Neurol; 2018 Jun; 38(3):316-329. PubMed ID: 30011412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal surface antibody-mediated autoimmune encephalitis.
    Linnoila JJ; Rosenfeld MR; Dalmau J
    Semin Neurol; 2014 Sep; 34(4):458-66. PubMed ID: 25369441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extreme delta - With or without brushes: A potential surrogate marker of disease activity in anti-NMDA-receptor encephalitis.
    Steriade C; Hantus S; Moosa ANV; Rae-Grant AD
    Clin Neurophysiol; 2018 Oct; 129(10):2197-2204. PubMed ID: 29580710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal central nervous system syndromes probably mediated by autoantibodies.
    Chefdeville A; Honnorat J; Hampe CS; Desestret V
    Eur J Neurosci; 2016 Jun; 43(12):1535-52. PubMed ID: 26918657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell targeted therapies in autoimmune encephalitis: mechanisms, clinical applications, and therapeutic potential.
    Shang H; Shen X; Yu X; Zhang J; Jia Y; Gao F
    Front Immunol; 2024; 15():1368275. PubMed ID: 38562943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuro-Ophthalmic Features of Autoimmune Encephalitides.
    Bohm PE; Chen JJ; Bhatti TM; Eggenberger ER
    J Neuroophthalmol; 2020 Sep; 40(3):385-397. PubMed ID: 32804457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoadsorption for autoimmune encephalitis.
    Fassbender C; Klingel R; Köhler W
    Atheroscler Suppl; 2017 Nov; 30():257-263. PubMed ID: 29096847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune dementia and encephalopathy.
    Flanagan EP; Drubach DA; Boeve BF
    Handb Clin Neurol; 2016; 133():247-67. PubMed ID: 27112681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Overview of Autoimmune and Paraneoplastic Encephalitides.
    Bradshaw MJ; Linnoila JJ
    Semin Neurol; 2018 Jun; 38(3):330-343. PubMed ID: 30011413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
    Dalmau J; Gleichman AJ; Hughes EG; Rossi JE; Peng X; Lai M; Dessain SK; Rosenfeld MR; Balice-Gordon R; Lynch DR
    Lancet Neurol; 2008 Dec; 7(12):1091-8. PubMed ID: 18851928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmunity in psychotic disorders. Where we stand, challenges and opportunities.
    Mané-Damas M; Hoffmann C; Zong S; Tan A; Molenaar PC; Losen M; Martinez-Martinez P
    Autoimmun Rev; 2019 Sep; 18(9):102348. PubMed ID: 31323365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic and autoimmune encephalopathies.
    O'Toole O; Clardy S; Lin Quek AM
    Semin Neurol; 2013 Sep; 33(4):357-64. PubMed ID: 24234357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.